Christopher Ray Aker, Sr. VP & General Counsel: Regulus Therapeutics RGLS Sell · Filed 25/01/15

Trade details

Type: Insider sale
Amount: $6,410.88
Shares · price: 5,088 sh · $1.26 a share
Held after: 49,546 sh
Stock: Regulus Therapeutics RGLS
Person: Christopher Ray AkerSr. VP & General Counsel
Trade date: 25/01/14
Filed: 25/01/15
Days to filing: 1 days

Sold 9.3% of holdings

Share of holding sold: 9.3%

Regulus Therapeutics trades, last 26 weeks

What else happened in Regulus Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/15~25/02/13

Christopher Ray Aker's recent trades

Christopher Ray AkerSr. VP & General Counsel
Sell10b5-1 planRegulus Therapeutics
Sell10b5-1 plan
Regulus Therapeutics
RGLS
$48.6K
38,547 sh
$48.6K
Filed 25/01/15
Traded 25/01/13
Christopher Ray AkerSr. VP & General Counsel
SellRegulus Therapeutics
Sell
Regulus Therapeutics
RGLS
$6,507
5,468 sh
$6,507
Filed 24/01/18
Traded 24/01/18